 students as 2022-2023 Niblack Research Scholars, each receiving $8,000 scholarships and the opportunity to conduct research guided by faculty sponsors and graduate student mentors. Ten students were selected from across campus.){kind=link}
Tuesday, October 25, 2022
Media Contact:
Kristi Wheeler | Manager, CEAT advertising and marketing and Communications | 405-744-5831 | [email protected]
Oklahoma State University has named three College of Engineering, Architecture and
Technology (CEAT) students as 2022-2023 Niblack Research Scholars, every receiving
$8,000 scholarships and the chance to conduct analysis guided by school sponsors
and graduate pupil mentors. Ten students have been chosen from throughout campus.
CEAT students chosen have been:
Brinkli Abbitt, Chemical Engineering, Oklahoma City, OK
Sam Glenn, Mechanical and Aerospace Engineering, Stillwater, OK
Samantha Stobbe, Chemical Engineering, Ponca City, OK
The Niblack Research Scholars program, administered by means of the OSU Office of the
Vice President for Research, is a novel probability for undergraduates to take what they
be taught within the classroom and apply it to precise analysis tasks.
The annual program is funded by OSU alumnus Dr. John Niblack and his spouse, Heidi Niblack.
As an undergraduate at OSU, Niblack stated his analysis expertise impacted the course
of his life. Niblack based the Niblack Research Scholarship in 2004 to supply OSU
undergraduates the identical analysis alternative he had.Â
About Dr. Niblack
John Niblack retired in 2002 as Vice Chairman of Pfizer Inc., a $32 billion pharmaceutical
firm that discovers, develops, manufactures, and markets main prescription medicines
for people and animals and most of the world’s best-known shopper manufacturers. As Vice
Chairman, Dr. Niblack was accountable for Pfizer’s Global Research and Development
Division and pharmaceutical Licensing and Development. As an lively scientist from
1967-1980, Niblack rose within the firm by means of a succession of positions through which
he directed analysis into medicine for viral sicknesses, most cancers and autoimmune issues.
In 1980 he was appointed director of analysis for the corporate’s US laboratories. In
1990, he was named president of Pfizer’s Central Research Division and in 1993 was
promoted to govt VP of Pfizer Inc. He has a BS in chemistry from OSU and a Ph.D.
in biochemistry from the University of Illinois.Â
publish credit score to Source link